Poming Kang

Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance

Quan Zhang, Tianyu Sun, Poming Kang et al. · Cancer Chemotherapy and Pharmacology · 2016 · 39 citations

Tumor Biology, Mrna Expression, Somatic Mutation +12

FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim

Tianyu Sun, Jingge Zhang, Bo Deng et al. · Acta Biochimica et Biophysica Sinica · 2020 · 27 citations

Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?

Shaolin Tao, Xuemei Wang, Yong‐Geng Feng et al. · Medical Hypotheses · 2020 · 25 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Advanced Lung Disease +22

Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report

Licheng Wu, Poming Kang, Shaolin Tao et al. · BMC Medical Genomics · 2020 · 15 citations · Full text

Risk factors of conversion in robotic- and video-assisted pulmonary surgery for non-small cell lung cancer

Dali Chen, Poming Kang, Shaolin Tao et al. · Updates in Surgery · 2021 · 15 citations

Computer-assisted Surgery, Medicine, Robotic Surgery +10